0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
Related JAMA Internal Medicine Collections
From The JAMA Network
JAMA Dermatology
Research Letter  | 
Risk for Nevus Transformation and Melanoma Proliferation and Invasion During Natalizumab Treatment:  Four Years of Dermoscopic Follow-up With Immunohistological Studies and Proliferation and Invasion Assays
Momen Pharaon, MD; Mélanie Tichet, MSc; Christine Lebrun-Frénay, MD, PhD; et al.
JAMA Dermatology
Editorial  | 
Melanoma Surveillance in “High-Risk” Individuals
Allan C. Halpern, MD; Michael A. Marchetti, MD; Ashfaq A. Marghoob, MD
JAMA Dermatology
Invited Commentary  | 
Methotrexate-Induced Liver Toxicity:  Replacing the Liver Biopsy
Bruce E. Strober, MD, PhD
JAMA Dermatology
Original Investigation  | 
The Use of Transient Elastography and FibroTest for Monitoring Hepatotoxicity in Patients Receiving Methotrexate for Psoriasis
Maeve Lynch, MB, BCh, BAO, MRCPI; Eleanor Higgins, MB, BCh, BAO, MRCPI; P. Aiden McCormick, MD, FRCPI; et al.